Popular diabetes and weight-loss drug may reduce risk of Alzheimer’s disease Post author: Post published:October 24, 2024 Post category:News Feed Post comments:0 Comments Researchers have found that semaglutide may lower the risk of Alzheimer’s disease in people with type 2 diabetes (T2D). You Might Also Like How many people have A-Fib? Three times more than we thought September 12, 2024 Wildfires linked to surge in mental health-related emergency department visits February 21, 2024 Psychosocial stressors linked to higher inflammation in Black pregnant women March 6, 2024 Leave a Reply Cancel replyCommentEnter your name or username to comment Enter your email address to comment Enter your website URL (optional) Save my name, email, and website in this browser for the next time I comment.